Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium phosphate is an inorganic salt mixture used as a phosphorus replacement product. It is primarily indicated for the treatment and prevention of hypophosphatemia in adult and pediatric patients when oral or enteral replacement is not possible, insufficient, or contraindicated. It is also used as an additive in parenteral nutrition to provide phosphorus and potassium. Phosphorus is an essential mineral for bone structure, energy metabolism (ATP), and cell membrane integrity, while potassium is the primary intracellular cation involved in nerve conduction and muscle contraction. The pharmaceutical product typically consists of a mixture of monobasic and dibasic potassium phosphate salts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium phosphate.